ABSTRACT Diabetic retinopathy and diabetic macular edema are leading causes of preventable vision loss, with a rising global impact due to the increasing prevalence of diabetes mellitus. This review article synthesizes current evidence regarding the management of diabetic retinopathy, addressing pathophysiological mechanisms and evidence-based therapeutic recommendations from major clinical trials. Key topics include screening strategies, updated classification systems, systemic control, and ocular therapies such as anti-vascular endothelial growth factor (anti-VEGF) agents, corticosteroids, laser photocoagulation, and vitrectomy. Emerging medication approaches, sustained-release […]